tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Advertisement

Taysha Gene Therapies (TSHA) Ownership - Who Owns Taysha Gene Therapies?

Compare
1,115 Followers

Taysha Gene Therapies (TSHA) Ownership Overview

12.42%9.62%56.51%7.52%13.92%
12.42% Insiders
56.51% Other Institutional Investors
7.52% ETFs
13.92% Public Companies and
Individual Investors
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 73.66% of the company’s stock is owned by Institutional Investors, 12.42% is owned by Insiders, and 13.92% is owned by Public Companies and Individual Investors.
The ownership structure of Taysha Gene Therapies (TSHA) stock is a mix of institutional, retail, and individual investors. Approximately 66.14% of the company’s stock is owned by Institutional Investors, 12.42% is owned by Insiders, and 7.52% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 22, 2025
xxxxxxxxxxxxx
$162604
Aug 22, 2025
xxxxxxxxxxxxx
$155299
Jun 03, 2025
xxxxxxxxxxxxx
$2062500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$159641
Jun 30, 2025
xxxxxxxxxxxxx
$2310586
Jun 30, 2025
xxxxxxxxxxxxx
$12441660
Jun 30, 2025
xxxxxxxxxxxxx
$54413546

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
25,601,110Insider9.38%78,595,408
23,555,648Institution8.63%72,315,839
9,848,654Institution3.61%30,235,368
9,046,544Institution3.32%27,772,890
7,920,223Institution2.90%24,315,085
6,800,181Institution2.49%20,876,556
5,386,000Institution1.97%16,535,020
4,004,756Institution1.47%12,294,601
3,804,276Institution1.39%11,679,127
3,613,903Insider1.32%11,094,682

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
9,046,544Institution3.32%27,772,890
6,800,181Institution2.49%20,876,556
3,804,276Institution1.39%11,679,127
1,930,488Institution0.71%5,926,598
1,469,614Institution0.54%4,511,715
1,056,536Institution0.39%3,243,566
565,855Institution0.21%1,737,175
442,311Institution0.16%1,357,895
341,218Institution0.13%1,047,539
128,966Institution0.05%395,926

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,633,024Institution2.43%18,108,156
4,137,736Institution1.52%12,702,850
1,606,573Institution0.59%4,385,944
1,498,348Institution0.55%4,854,648
1,456,439Institution0.53%4,471,268
1,297,894Institution0.48%3,984,535
789,420Institution0.29%2,155,117
390,253Institution0.14%1,198,077
348,758Institution0.13%952,109
277,734Institution0.10%899,858

FAQ

Who Owns Taysha Gene Therapies (TSHA)?
According to the latest TipRanks data, approximately 56.51% of the company's stock is held by institutional investors, 12.42% is held by insiders, and 13.92% is held by retail investors.
    What percentage of Taysha Gene Therapies (TSHA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 56.51% of Taysha Gene Therapies (TSHA) stock is held by institutional investors.
      What percentage of Taysha Gene Therapies (TSHA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.92% of Taysha Gene Therapies (TSHA) stock is held by retail investors.
        Who owns the most shares of Taysha Gene Therapies (TSHA)?
        Paul B Manning owns the most shares of Taysha Gene Therapies (TSHA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis